In a study conducted by Au SL et al. it was revealed that EZH2 can epigenetically inhibit the expression of tumor-suppressor miRNAs, such as miR-139-5p, miR-125b, miR-101, let-7c, and miR-200b in HCC (35). The gene discussed is EZH2; the disease is hepatocellular carcinoma.